Skip to main content
Contact Us
Subscribe
E-Edition
77°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Apple Thwarts $2B In Fraud Transactions, UBS Takes $17B Hit From 'Hasty Credit Suisse Takeover,' Verizon Streamlines Unlimited Data Plans: Today's Top Stories
May 17, 2023
Tickers
ABBV
AZN
BCS
CS
Tags
BCS
JNJ
ABBV
From
Benzinga
Roche's Investigational Drug For Relapsing Multiple Sclerosis Reduces Brain Lesions, Data Shows
May 17, 2023
Tickers
MKGAF
RHHBF
RHHBY
RHHVF
Tags
Biotech
Benzinga
MKGAF
From
Benzinga
AI Meets Biotech: Transforming the Drug Development Process
May 16, 2023
Tickers
AZN
BAYRY
RHHBY
SNY
Tags
SNY
Uncategorized
OTCMKTS:BAYRY,OTCMKTS:RHHBY,Nasdaq:SNY,Nasdaq:AZN
From
InvestorPlace
3 Stocks That Are Reshaping the Future
May 16, 2023
Tickers
MSFT
RHHBY
ZBH
Tags
ZBH
Market News
MSFT
From
InvestorPlace
3 Personalized Medicine Stocks to Buy for Long-Time Returns
May 15, 2023
Tickers
ADPT
EXAS
GSK
ME
Tags
ME
Market News
NASDAQ:EXAS,NYSE:GSK,NASDAQ:ADPT,OCTMKTS:RHHBY,NASDAQ:ME
From
InvestorPlace
EXCLUSIVE: SAB Biotherapeutics' Influenza Immunotherapy Shows Safety, Efficacy In Early-Stage Trials
May 04, 2023
Tickers
RHHBY
SABS
Tags
General
Benzinga
Biotech
From
Benzinga
Tempest Therapeutics' TPST-1120 Shines In Early Phase 1b/2 Study: Analysts Get Bullish
April 28, 2023
Tickers
RHHBY
TPST
Tags
General
Benzinga
Movers
From
Benzinga
Roche's Q1 Highlights: Increased Uptake Of Eye Disease Drug Cushions Sales Decline
April 26, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHVF
General
RHHBF
From
Benzinga
EXCLUSIVE: SAB Biotherapeutics Releases Topline Data From Discontinued COVID Antibody Trial
April 26, 2023
Tickers
REGN
RHHBY
SABS
Tags
Biotech
Health Care
Penny Stocks
From
Benzinga
3 Top Biotech Stocks Defying the Bear Market
April 25, 2023
Tickers
BGNE
BIIB
LLY
NVS
Tags
Market News
NVS
TGTX
From
Motley Fool
This Company's Non-Invasive Tech Looks To Be Unique In the Market And Can Help People Take Ownership Over Monitoring Their Health
April 25, 2023
Tickers
ABT
DXCM
RHHBY
TECH
Tags
Tech
Health Care
ABT
From
Benzinga
FDA Approves Roche's Polivy Combo Therapy For Untreated Patients With Diffuse Large B-Cell Lymphoma
April 20, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBF
FDA
General
From
Benzinga
EXCLUSIVE: FDA Grants Expedited Review Status To SAB Biotherapeutics' Influenza Antibody
April 13, 2023
Tickers
RHHBF
RHHBY
RHHVF
SABS
Tags
Health Care
Penny Stocks
Exclusives
From
Benzinga
Why Shares of Adaptimmune Therapeutics Jumped Tuesday
April 11, 2023
Tickers
ADAP
GSK
RHHBY
Tags
ADAP
Recent Press Releases
GSK
From
Motley Fool
Bolt Biotherapeutics Says Phase 1 Data Supports Advancing Into Phase 2 Studies
March 30, 2023
Tickers
BMY
BOLT
RHHBY
Tags
Market News
RHHBY
BMY
From
Benzinga
Roche's Slow Growth Shouldn't Drive Investors Away
March 28, 2023
Tickers
RHHBY
Tags
RHHBY
Recent Press Releases
Market News
From
Motley Fool
Roche Joins Hand With Lilly To Improve Early Diagnosis Of Alzheimer's Disease
March 22, 2023
Tickers
LLY
RHHBY
Tags
News
Briefs
Benzinga
From
Benzinga
New Four Year Data For Roche's Evrysdi Reinforces Long-Term Efficacy, Safety Profile In Muscular Atrophy Patients
March 20, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBY
Market News
News
From
Benzinga
Is Roche a Buy Now?
March 20, 2023
Tickers
RHHBY
Tags
Recent Press Releases
Market News
RHHBY
From
Motley Fool
Sarepta Plunges As FDA Takes Surprise Turn; AdComm Meeting Set For Duchenne Gene Therapy
March 17, 2023
Tickers
RHHBY
SRPT
Tags
why it's moving
SRPT
RHHBY
From
Benzinga
FDA Casts Doubts Over Roche's Polivy Label Expansion For Untreated Lymphoma Setting
March 09, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
FDA
RHHBF
RHHVF
From
Benzinga
The Top 7 Growth Stocks in Biotech
March 03, 2023
Tickers
APVO
BEAM
CMRX
DVAX
Tags
RHHBY
DVAX
CMRX
From
InvestorPlace
Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo
March 03, 2023
Tickers
EXEL
RHHBF
RHHBY
RHHVF
Tags
Benzinga
Biotech
Briefs
From
Benzinga
Why Sarepta Therapeutics' Shares Rose 23.4% This Week
March 02, 2023
Tickers
RHHBY
SRPT
Tags
Recent Press Releases
Market News
SRPT
From
Motley Fool
3 Best Growth Stocks to Buy In March
March 02, 2023
Tickers
HIMS
IWF
MELI
RHHBY
Tags
Recent Press Releases
MELI
IWF
From
Motley Fool
Blueprint Medicines Highlights Detailed Data From Lead Product In Blood Cancer Patients
February 27, 2023
Tickers
BPMC
RHHBY
Tags
Benzinga
Health Care
Biotech
From
Benzinga
Roche Decides To Terminate Cancer Treatment Pact With Blueprint Medicines
February 23, 2023
Tickers
BPMC
RHHBF
RHHBY
RHHVF
Tags
Contracts
RHHBY
Market News
From
Benzinga
Infinity Pharmaceuticals Announce Merger Agreement With MEI Pharma, Share Plunge
February 23, 2023
Tickers
ABBV
INFI
MEIP
MRK
Tags
MEIP
News
Health Care
From
Benzinga
New Data Shows Roche's Vabysmo Improves Vision, Retinal Fluid In Retinal Disorder
February 10, 2023
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
RHHBY
Market News
News
From
Benzinga
Roche Touts Positive Crovalimab Data From Late-Stage Study In Rare Blood Condition
February 07, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBF
RHHVF
General
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.